Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | PSMD10 | O75832 | 1/20 | 0.39 |
| ▸ | CYP24A1 | Q07973 | 2/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | MMP13 | P45452 | 1/20 | 0.38 |
| ▸ | STAT3 | P40763 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | G6PD | P11413 | 1/20 | 0.37 |
| ▸ | VDR | P11473 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16599488 | 0.95 | CA12 (0.39) | CA12CA1CA9ALDH1A1CYP3A4 | |
| SCHEMBL26634633 | 0.94 | CA12 (0.38) | CA12CA1CA9ALDH1A1CYP3A4 | |
| SCHEMBL21179227 | 0.94 | CA12 (0.38) | CA12CA1CA9ALDH1A1CYP3A4 | |
| SCHEMBL18301202 | 0.94 | CA12 (0.38) | CA12CA1CA9ALDH1A1CYP3A4 | |
| SCHEMBL15881370 | 0.94 | CA12 (0.38) | CA12CA1CA9ALDH1A1CYP3A4 | |
| SCHEMBL31556805 | 0.94 | CA12 (0.38) | CA12CA1CA9ALDH1A1CYP3A4 | |
| SCHEMBL31556837 | 0.94 | CA12 (0.38) | CA12CA1CA9ALDH1A1CYP3A4 | |
| SCHEMBL13884657 | 0.94 | CA12 (0.38) | CA12CA1CA9ALDH1A1CYP3A4 | |
| SCHEMBL15264830 | 0.94 | CA12 (0.38) | CA12CA1CA9ALDH1A1CYP3A4 | |
| SCHEMBL26049382 | 0.91 | ALDH1A1 (0.40) | CA12CA1CA9ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119176793-A | Synthesis method and application of targeted degradation chimeric | 西华大学 | 2024-12-24 | — | — | CN | claimed |
| US-20250236607-A1 | CYCLIN-DEPENDENT KINASE 9 (CDK9) DEGRADERS AND METHODS OF USING THEREOF | OHIO STATE INNOVATION FOUNDATION | 2025-07-24 | — | — | US | disclosed |
| EP-4561585-A1 | IP4-4,6 SUBSTITUTED DERIVATIVE COMPOUNDS FOR USE IN THE TREATMENT, INHIBITION OF PROGRESSION, AND PREVENTION OF ECTOPIC CALCIFICATION | Sanifit Therapeutics S.A. (ES) | 2025-06-04 | — | — | EP | disclosed |
| EP-4562019-A1 | IP5 SUBSTITUTED COMPOUNDS | Sanifit Therapeutics S.A. (ES) | 2025-06-04 | — | — | EP | disclosed |
| US-20250172566-A1 | SACCHARIDE SENSING SYSTEMS | Carbometrics Limited (GB) | 2025-05-29 | — | — | US | disclosed |
| CN-119855595-A | IP4-4,6 substituted derivative compounds for treating ectopic calcification, inhibiting progression and preventing ectopic calcification | 萨尼菲特治疗有限公司 | 2025-04-18 | — | — | CN | disclosed |
| EP-4536668-A1 | PYRIDO[4,3-D]PYRIMIDINE DERIVATIVES AS KRAS INHIBITORS | Bristol-Myers Squibb Company (US) | 2025-04-16 | — | — | EP | disclosed |
| WO-2025075958-A1 | POLYMER-FUNCTIONALIZED RETICULAR MATERIALS FOR CARBON DIOXIDE CAPTURE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-04-10 | — | — | WO | disclosed |
| CN-119630679-A | IP5 substituted compounds | 萨尼菲特治疗有限公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-119630676-A | Pyrido [4,3-D ] pyrimidine derivatives as KRAS inhibitors | 百时美施贵宝公司 | 2025-03-14 | — | — | CN | disclosed |
| US-20140066576-A1 | SWITCHABLE IONIC ADHESIVE COATING FOR RECYCLABLE CARBON FIBER | EMPIRE TECHNOLOGY DEVELOPMENT LLC | 2014-03-06 | — | — | US | disclosed |
| US-20140066576-A1 | SWITCHABLE IONIC ADHESIVE COATING FOR RECYCLABLE CARBON FIBER | EMPIRE TECHNOLOGY DEVELOPMENT LLC | 2014-03-06 | — | — | US | disclosed |
| CN-101679430-B | 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of ORL-i receptor for treatment of anxiety and depression | JANSSEN PHARMACEUTICA NV | 2013-12-25 | — | — | CN | disclosed |
| US-20120028249-A1 | ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF | Life Technologies Corporation (US) | 2012-02-02 | — | — | US | disclosed |
| US-20120028249-A1 | ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF | Life Technologies Corporation (US) | 2012-02-02 | — | — | US | disclosed |
| US-20100247439-A1 | DENDRITIC NANO-ANTIOXIDANTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-09-30 | — | — | US | disclosed |
| CN-101679430-A | 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the ORL-i receptor for the treatment of anxiety and depression | JANSSEN PHARMACEUTICA NV | 2010-03-24 | — | — | CN | disclosed |
| EP-1862466-A2 | Arrays with cleavable linkers | The Scripps Research Institute (US) | 2007-12-05 | — | — | EP | disclosed |
| US-20070213278-A1 | Arrays with cleavable linkers | SCRIPPS RESEARCH INSTITUTE, THE | 2007-09-13 | — | — | US | disclosed |
| US-20070213297-A1 | Arrays with cleavable linkers | SCRIPPS RESEARCH INSTITUTE, THE | 2007-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120028249-A1 | ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF | ANTXR2, AAAS, IK | CA12 1502/4885CA1 1493/4885CA9 1207/4885 |
| US-20070213278-A1 | Arrays with cleavable linkers | ENGASE, ADAM33, SIGLEC7 | CA12 68/4885CA1 264/4885CA9 458/4885 |
| US-20100247439-A1 | DENDRITIC NANO-ANTIOXIDANTS | GPX1, GPX4, LPO | CA12 3449/4885CA1 3330/4885CA9 4002/4885 |
| US-20070213297-A1 | Arrays with cleavable linkers | ENGASE, ADAM33, SIGLEC7 | CA12 68/4885CA1 264/4885CA9 458/4885 |
| US-20140066576-A1 | SWITCHABLE IONIC ADHESIVE COATING FOR RECYCLABLE CARBON FIBER | ILK, VIM, EPCAM | CA12 196/4885CA1 101/4885CA9 130/4885 |
| US-20250236607-A1 | CYCLIN-DEPENDENT KINASE 9 (CDK9) DEGRADERS AND METHODS OF USING THEREOF | CDK9, CDK19, CDKL2 | CA12 3413/4885CA1 3914/4885CA9 498/4885 |
| US-20250172566-A1 | SACCHARIDE SENSING SYSTEMS | GALE, SLC2A8, SLC2A4 | CA12 253/4885CA1 1185/4885CA9 582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.